Stock Market & Financial Investment News

News Breaks January 18, 2013 07:21 EDT JAZZ Jazz Pharmaceuticals price target raised to $87 from $76 at Lazard Capital Lazard Capital raised its price target fort Jazz Pharmaceuticals citing expectations for robust Xyrem revenue growth and keeps a Buy rating on the stock. News For JAZZ From The Last 14 Days Check below for free stories on JAZZ the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 20, 2013 11:18 EDT JAZZ High option volume stocks: JASO QUIK FWLT NM JAZZ Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.